Venture-Backed Startups

Biopremier supplies molecular diagnostic products and laboratory equipment, including real-time PCR and ELISA test kits for detecting pathogens, mycotoxins, and food adulteration in food, animal feed, and environmental and veterinary samples. It also provides laboratory instruments and services such as biosafety cabinets, plate readers, and molecular biology lab setup and training for food safety and veterinary diagnostics.

1 investor

BioPrex Medical develops permanent antimicrobial coatings for biomedical devices, using immobilized biocidal quaternary ammonium compounds (QACs) that kill bacteria on contact without leaching into body fluids. The non-leaching, contact-killing coatings are effective against both Gram-positive and Gram-negative bacteria and adaptable to a variety of surfaces.

1 investor

0 investors

BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.

1 investor

Bioptimus builds multimodal foundation models for biology, including H-Optimus for histology and M-Optimus which integrates pathology, spatial transcriptomics, and genomics, to extract clinically relevant insights from patient data. Its models serve pharmaceutical companies, researchers, and clinical practices for applications such as drug target prediction, patient stratification in trials, and biomarker discovery.

7 investors

0 investors

Bondwell Technologies develops a protein-based biomaterial platform that uses proteins to create materials for applications across energy, environmental, and medical fields. The company was founded by Texas A&M University scientists and is based in College Station, Texas.

1 investor

BioQ Pharma develops invenious, a patented "connect-and-go" delivery platform for infusible medicines that provides all-in-one, pre-filled, ready-to-use delivery systems tailored to specific dosing regimens. The technology targets drugs that are hard to prepare or administer and serves patients, healthcare providers, and payers.

0 investors

Bioqore builds Voyager, an AI-powered closed-loop bioprocess intelligence platform that combines predictive modeling with micro-scale laboratory experiments to recommend and validate optimal process conditions for producing preclinical- and clinic-ready therapeutic candidates. It serves biotech and pharma teams working on bioprocess development, scale-up, and biomanufacturing.

3 investors

BioRaptor provides a bioprocess data management platform that stores and analyzes biological metrics to help biotechnology teams move from trial-and-error to optimized experimentation. The platform serves bioprocessing teams in R&D, scale-up, and production by making scientific data connected, contextualized, and actionable.

2 investors

Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.

2 investors

BioReact provides a data integration platform that unifies experimental data from bioreactors, laboratory instruments, and omics workflows into a standardized, AI-ready format for bioprocess development. The platform serves scientists in synthetic biology, cell therapy, biologics, and precision fermentation who need to consolidate fragmented scientific data for analytics and machine learning.

5 investors

0 investors

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.

2 investors

BioRegenx is a health-technology holding company developing and acquiring patented regenerative biotherapeutics, anti-aging nutraceuticals, and AI-based health monitoring tools, including non-invasive microvascular imaging (GlycoCheck), a plant-based supplement (Endocalyx Pro), and contactless vital-sign analysis (DocSun). It sells through direct-to-institution, direct-to-practitioner, and direct-to-consumer models across the health, wellness, and longevity market.

0 investors

Biorelate develops Galactic AI, a data curation and knowledge graph platform that automatically identifies causal relationships between drugs, genes, and diseases from biomedical literature. It serves biopharmaceutical companies and biotech firms conducting drug discovery research.

2 investors

0 investors

BioRender is a software tool that enables scientists to create and share professional scientific illustrations and figures. The platform serves researchers and scientists across life sciences disciplines globally.

4 investors

0 investors

0 investors

BioRestore is a healthcare clinic offering age-related and wellness treatments, including hormone/regenerative therapies and non-invasive pain treatments such as Bio Wave therapy, delivered by clinicians like nurse practitioners and physicians. It serves individual patients seeking evidence-based, patient-centric care, with a presence in New England.

1 investor

Bioretec develops fully biodegradable orthopedic implants for fracture healing and orthopedic surgery, including the RemeOs product line based on magnesium alloy and the Activa line of bioabsorbable implants. The company serves orthopedic surgeons and patients globally across approximately 40 countries.

1 investor

0 investors

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions. The company combines neural engineering with AI and machine learning to improve healthcare outcomes and restore patient control over bodily function.

5 investors